Understand the exposure
The 2024 source article highlighted PFAS used in device and diagnostic manufacturing, including process aids, lubricants, and coatings. A material may matter to production even when it does not appear in the finished product’s bill of materials. Supplier decisions can create disruption before regulatory deadlines arrive.
Coordinate the response
Trace critical materials through suppliers and production steps. Assess substitute performance, qualification, regulatory implications, inventory, and transition lead times together. Quality, engineering, procurement, and regulatory teams need one coordinated plan. The article’s supply forecasts were time-specific; the enduring recommendation is to verify actual exposure and supplier readiness rather than assume a distant regulatory timeline provides protection.